Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 19,765 full-time employees. The company went IPO on 2005-09-28. The firm is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The firm is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.
How did DSNKY's recent EPS compare to expectations?
The most recent EPS for Daiichi Sankyo Company, Limited is $23.03, 殴打しない expectations of $48.55.
How did Daiichi Sankyo Company, Limited DSNKY's revenue perform in the last quarter?
Daiichi Sankyo Company, Limited revenue for the last quarter is $23.03
What is the revenue estimate for Daiichi Sankyo Company, Limited?
According to 7 of Wall street analyst, the revenue estimate of Daiichi Sankyo Company, Limited range from $585.9B to $486.17B
What's the earning quality score for Daiichi Sankyo Company, Limited?
Daiichi Sankyo Company, Limited has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Daiichi Sankyo Company, Limited report earnings?
Daiichi Sankyo Company, Limited next earnings report is expected in 2026-08-09
What are Daiichi Sankyo Company, Limited's expected earnings?
Daiichi Sankyo Company, Limited expected earnings is $598.84B, according to wall-street analysts.
Did Daiichi Sankyo Company, Limited beat earnings expectations?
Daiichi Sankyo Company, Limited recent earnings of $598.58B 打ち勝たない expectations.